The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of hepatic impairment on the pharmacokinetics of ripretinib.
 
Xiaoyan Li
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera
 
Charles M Psoinos
Employment - Biogen; Deciphera
Stock and Other Ownership Interests - Abbvie; Deciphera; Johnson & Johnson/Janssen; Pfizer; Viatris
 
Mark Joel Shelton
Employment - Certara Inc
Stock and Other Ownership Interests - BioCryst; Certara Inc; Chimeric Therapeutics
 
Farida Abane
No Relationships to Disclose
 
Mark A. Matson
Employment - Prism Research
Consulting or Advisory Role - Astrocyte Pharmaceuticals
Research Funding - Prism Research (Inst)
 
Samuel Oberstein
No Relationships to Disclose
 
Rodrigo Ruiz-Soto
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera; Immunogen
Patents, Royalties, Other Intellectual Property - I am an inventor in 3 patents with Immunogen, I transferred the rights to Immunogen. I have not received (and I will not receive) any royalties; I am an inventor in pending patents at Deciphera. I have transferred the rights to Deciphera, I have not received (and will not receive) any royalties